|
Market Closed -
Hong Kong S.E.
12:08:32 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.17 HKD | -0.89% |
|
-0.45% | -6.68% |
| 09-04 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 09-03 | Simcere Pharmaceutical Group Limited Announces Approval for Marketing of Yingmule in China | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.69B | |||||
| 46.78B | |||||
| 37.88B | |||||
| 11.82B | |||||
| 11.61B | |||||
| 9.12B |
Select your edition
All financial news and data tailored to specific country editions
